Max Higgins, Consultant, Author at EverGlade Consulting - Page 2 of 7

Max Higgins, Consultant

Max Higgins, Consultant

DOE unveils $1B in critical mineral funding

Leave a Comment / DOE, Emerging Technologies / By

Introduction The U.S. Department of Energy (DOE) has announced nearly $1 billion in funding to strengthen domestic critical minerals supply chains. This initiative targets mining, processing, and manufacturing technologies for essential materials such as rare earths, battery components, and specialty elements. It represents a major opportunity for companies prepared to advance clean energy, semiconductors, and […]

DOE unveils $1B in critical mineral funding Read More »

Inside the New Executive Order on Strategic API Reserves

Leave a Comment / ASPR-IBx, Life Sciences / By

Introduction On August 13, 2025, President Trump signed a sweeping Executive Order titled “Ensuring American Pharmaceutical Supply Chain Resilience by Filling the Strategic Active Pharmaceutical Ingredients Reserve.” The order addresses a long-standing vulnerability in the U.S. healthcare system, the nation’s heavy reliance on foreign suppliers for the active pharmaceutical ingredients (APIs) that make up the

Inside the New Executive Order on Strategic API Reserves Read More »

DTRA’s “Plume” RFI for Marine Toxin Aerosol Exposure Models

Leave a Comment / DTRA, Life Sciences / By

Advancing Countermeasures for Marine Toxin Threats The Defense Threat Reduction Agency (DTRA), through its Research and Development Chemical and Biological Technologies Directorate in support of the Joint Science and Technology Office (JSTO), has issued a Request for Information (RFI) titled “Plume”. This initiative seeks information on the capabilities and availability of suitable animal models for

DTRA’s “Plume” RFI for Marine Toxin Aerosol Exposure Models Read More »

Navigating the SF-1408: A Guide to Pre-Award Accounting System Approval

Leave a Comment / Guides, Life Sciences / By

For companies eager to break into the federal market, the compliance landscape can feel like a maze of unfamiliar acronyms and requirements. One of the earliest and most critical checkpoints in this journey is the SF-1408: Pre-Award Survey of Prospective Contractor’s Accounting System. If you are bidding on a cost-reimbursement or time-and-materials contract, you will

Navigating the SF-1408: A Guide to Pre-Award Accounting System Approval Read More »

BARDA’s Onshoring of Viral Hemorrhagic Fevers Vaccine Candidates

Leave a Comment / BARDA, Life Sciences / By

As the global health landscape evolves, so too must the United States’ ability to respond rapidly to biological threats. To strengthen its readiness posture, the Biomedical Advanced Research and Development Authority (BARDA), in coordination with the Administration for Strategic Preparedness and Response (ASPR), has released a new opportunity under the BioMaP Consortium OT Vehicle. This

BARDA’s Onshoring of Viral Hemorrhagic Fevers Vaccine Candidates Read More »

DARPA NODES

DARPA Launches NODES to Revolutionize Protein Function Prediction

Leave a Comment / DARPA, Emerging Technologies / By

DARPA-PS-25-30 Program Solicitation Network of Optimal Dynamic Energy Signatures (NODES) On July 31, 2025, the Defense Advanced Research Projects Agency (DARPA), through its Biological Technologies Office (BTO), released a new program solicitation titled Network of Optimal Dynamic Energy Signatures (NODES). This initiative seeks to unlock a deeper understanding of protein functions by moving beyond static

DARPA Launches NODES to Revolutionize Protein Function Prediction Read More »

DTRA RAVEN Program

DTRA’s Reimagining the Next Generation of Biodefense Vaccines

Leave a Comment / DTRA, Life Sciences / By

Reimagining the Next Generation of Biodefense Vaccines: DTRA’s RAVEN Opportunity The Defense Threat Reduction Agency (DTRA), through its Joint Science and Technology Office (JSTO) and the Research and Development-Chem/Bio Medical Vaccines (RD-CBMV) division, has launched the Reimagining Available Vaccines and Envisioning Novelty (RAVEN) initiative. This forward-looking program is designed to modernize the nation’s medical countermeasure

DTRA’s Reimagining the Next Generation of Biodefense Vaccines Read More »

JPEO RFI u.s. military protective systems

U.S. Army Seeks Breakthrough Concepts to Combat Contaminant Infiltration in Protective Systems

Leave a Comment / JPEO, Life Sciences / By

Overview In a Request for Information (RFI), the Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Protection (JPM CBRN P), has called on industry, academia, and non-traditional innovators to help reimagine how protective gear prevents the infiltration of harmful airborne particles and vapors. This initiative aims to address a longstanding issue known as the

U.S. Army Seeks Breakthrough Concepts to Combat Contaminant Infiltration in Protective Systems Read More »

protein moecules

DARPA’s NODES Program to Decode the Protein Universe Through AI and Biophysics

Leave a Comment / DARPA, Emerging Technologies / By

The Defense Advanced Research Projects Agency (DARPA) has launched a new initiative to advance the understanding of protein molecular function based on sequence and structural data. With over 300 million protein sequences and structures cataloged, but only 1% functionally characterized, DARPA’s Network of Optimal Dynamic Energy Signatures (NODES) program seeks to transform our ability to

DARPA’s NODES Program to Decode the Protein Universe Through AI and Biophysics Read More »

Enzyme structure with biological concept 3d rendering

BARDA Solicits Enzymatic Debridement Solutions

Leave a Comment / All Posts, BARDA, Life Sciences / By

BARDA RFP – Enzymatic Debridement Products for Treatments of Deep and Full- Thickness Severe Burn Injuries – 75A50125R00007 – Amendment 0001 The Biomedical Advanced Research and Development Authority (BARDA), a division of the U.S. Department of Health and Human Services (HHS), has released a significant new opportunity to strengthen national preparedness for burn mass casualty

BARDA Solicits Enzymatic Debridement Solutions Read More »

Biothreat Pathogens

BARDA Launches RFP for vaccines targeting Marburg virus (MARV) and Sudan ebolavirus (SUDV)

Leave a Comment / BARDA, Life Sciences / By

BARDA RFP – Marburg Virus and Sudan Ebolavirus Vaccine Licensure and Procurement On July 12, 2025, the Biomedical Advanced Research and Development Authority (BARDA) issued Request for Proposals (RFP) #75A50125R00006. This RFP seeks proposals for the advanced development, FDA licensure, and procurement of vaccines targeting Marburg virus (MARV) and Sudan ebolavirus (SUDV). With recent outbreaks

BARDA Launches RFP for vaccines targeting Marburg virus (MARV) and Sudan ebolavirus (SUDV) Read More »

Close up of blue antibiotic capsules

BARDA Launches New RFP to Bolster Antibiotic Stockpiles Against Drug-Resistant and Biothreat Pathogens

Leave a Comment / BARDA, Life Sciences / By

Request for Proposals (RFP) for Antibiotic for Treatment of Bacterial Pneumonia or Bloodstream Infections Bolstering Biodefense with Advanced Antibiotics: BARDA’s Strategic Move As the threat of antibiotic-resistant infections intensifies, the U.S. Department of Health and Human Services (HHS), through the Biomedical Advanced Research and Development Authority (BARDA), has issued a pivotal solicitation under Project BioShield

BARDA Launches New RFP to Bolster Antibiotic Stockpiles Against Drug-Resistant and Biothreat Pathogens Read More »

Scroll to Top